Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects
International Immunopharmacology · 2023-10 · 123 · 110744
DOI: 10.1016/j.intimp.2023.110744 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Immunopharmacology, 2023-10. Verfasst von Yuanyuan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, Ch…. Hauptthemen laut MEDLINE: Stroke, Brain Injuries, Brain Edema. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 176 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Intracerebral hemorrhage (ICH) is a stroke subtype characterized by non-traumatic rupture of blood vessels in the brain, resulting in blood pooling in the brain parenchyma. Despite its lower incidence than ischemic stroke, ICH remains a significant contributor to stroke-related mortality, and most survivors experience poor outcomes that significantly impact their quality of life. ICH has been accompanied by various complex pathological damage, including mechanical damage of brain tissue, hematoma mass effect, and then leads to inflammatory response, thrombin activation, erythrocyte lysis, excitatory amino acid toxicity, complement activation, and other pathological changes. Accumulating evidence has demonstrated that activation of complement cascade occurs in the early stage of brain injury, and the excessive complement activation after ICH will affect the occurrence of secondary brain injury (SBI) through multiple complex pathological processes, aggravating brain edema, and pathological brain injury. Therefore, the review summarized the pathological mechanisms of brain injury after ICH, specifically the complement role in ICH, and its related pathological mechanisms, to comprehensively understand the specific mechanism of different complements at different stages after ICH. Furthermore, we systematically reviewed the current state of complement-targeted therapies for ICH, providing a reference and basis for future clinical transformation of complement-targeted therapy for ICH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China; Institute for Brain Disorders, Beijing University of Chinese Medi…
- Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
- Guang'an Men Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Electronic address: xingyanwei12345@163.com.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Li, Y., Tao, C., An, N., Liu, H., Liu, Z., Zhang, H., Sun, Y., Xing, Y., & Gao, Y. (2023). Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects. International Immunopharmacology, 123, 110744. https://doi.org/10.1016/j.intimp.2023.110744
Vancouver
Li Y, Tao C, An N, Liu H, Liu Z, Zhang H, et al. Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects. International Immunopharmacology. 2023;123:110744. doi:10.1016/j.intimp.2023.110744
BibTeX
@article{Li2023,
author = {Li, Yuanyuan and Tao, Chenxi and An, Na and Liu, Haoqi and Liu, Zhenhong and Zhang, Hongrui and Sun, Yikun and Xing, Yanwei and Gao, Yonghong},
title = {Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects},
journal = {International Immunopharmacology},
year = {2023},
volume = {123},
pages = {110744},
doi = {10.1016/j.intimp.2023.110744}
}
EUVIMED